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Background: Behavioral change is the key to alter individuals’ lifestyle from sedentary to
active. The aim was to assess the feasibility of delivering a Lifestyle-integrated Functional
Exercise programme and evaluate the delivery of the intervention by use of digital
technology (eLiFE) to prevent functional decline in 61–70 year-old adults.
Methods: This multicentre, feasibility randomized controlled trial was run in three
countries (Norway, Germany, and the Netherlands). Out of 7,500 potential participants,
926 seniors (12%) were screened and 180 participants randomized to eLiFE (n = 61),
aLiFE (n = 59), and control group (n = 60). eLiFE participants used an application on
smartphones and smartwatches while aLiFE participants used traditional paper-based
versions of the same lifestyle-integrated exercise intervention. Participants were followed
for 12 months, with assessments at baseline, after a 6 month active trainer-supported
intervention, and after a further 6months of unsupervised continuation of the programme.
Results: At 6 months, 87% of participants completed post-test, and 77% completed
the final assessment at 12 months. Participants were willing to be part of the programme,
with compliance and reported adherence relatively high. Despite small errors during
start-up in the technological component, intervention delivery by use of technology
appeared acceptable. No serious adverse events were related to the interventions. All
groups improved regarding clinical outcomes over time, and complexity metrics show
potential as outcome measure in young seniors.
Taraldsen et al. PreventIT—Lifestyle-Integrated Exercise
Conclusion: This feasibility RCT provides evidence that an ICT-based lifestyle-integrated
exercise intervention, focusing on behavioral change, is feasible and safe for
young seniors.
Clinical Trial Registration: ClinicalTrials.gov, identifier: NCT03065088. Registered on
14 February 2017.
Keywords: physical activity, muscle strength, balance, behavioral change, mHealth
INTRODUCTION
Western societies mostly enjoy a steadily increasing life
expectancy (1), but the majority of older citizens spend their life
with morbidities and disabilities that ultimately require care (2).
The pace of this change and its social, economic and health-care
consequences have not been adequately addressed (3). A shift in
focus from treatment toward prevention of age-related diseases
and disability, by promoting active and healthy aging, is highly
warranted (4), but effective strategies are yet to be established.
Behavioral change is the key to alter individuals’ lifestyle from
sedentary to active. However, long-term adherence to physical
activity interventions is challenging, with activity levels typically
reverting back to previous low levels after an intervention (5, 6).
There is an imperative to develop effective strategies promoting
physical activity, which are acceptable and sustainable over the
long term. Activity programmes that are multi-dimensional and
integrated into daily life have shown to positively influence
habit formation, improve function and decrease disability when
compared to “traditional” exercise that are segregated from daily
routines (7). Integrating tailored activities into daily life has been
shown to be effective in adults aged over 70 years, however
this approach has not yet been adopted to prevent accelerated
functional decline in young seniors aged between 61 and
70 years.
Information and communication technology (ICT) is
increasingly used to deliver healthcare and behavioral change
interventions (8–10). These electronic health interventions
(eHealth) make use of electronic devices such as computers,
smartphones or smartwatches to deliver or assist interventions.
The digital environment enables feedback and tailored
interventions at an individual level (9, 11, 12). eHealth
interventions for promoting an active lifestyle, including
an increase in physical activity, are promising and show
a positive short-term effect on physical activity, but long-
term effects on sustained behavioral change have yet to be
established (9).
The PreventIT project is a European Horizon 2020 Personal
Health and Care project, aimed to develop and test a personalized
behavior change intervention on physical activity for young
seniors at risk for accelerated functional decline (13). The original
Lifestyle-integrated Exercise (LiFE) programme developed by
Clemson et al. (7) was adapted to the needs of young seniors,
tailoring exercise at an individual level and integrating it into
daily life, delivered by either a traditional paper-based adapted
manual (aLiFE) or enhanced by an eHealth smartphone and
smartwatch-based system (eLiFE).
The primary aim was to test the feasibility of integrating
physical activities into daily life of young seniors aged 61–
70 years by the aLiFE or eLiFE programme, compared to a
control group who received general written physical activity
recommendations only. To evaluate and further improve the
intervention for a future phase III clinical trial, the evaluation
addressed participation and adherence; feasibility and usability
of the programmes; acceptability of eLiFE delivered using
smartphone and smartwatch technology; estimates of change
in function and physical activity; and feasibility of health
economics evaluation.
METHODS
The PreventIT feasibility randomized controlled trial has been
conducted according to the detailed description in the published
protocol (13).
Trial Design and Participants
This three-armed, feasibility randomized controlled trial was
ethically approved and was run from March 2017 until
August 2018 at three clinical sites: Trondheim, Norway (REK
midt, 2016/1891), Stuttgart, Germany (registration number
770/2016BO1), and Amsterdam, The Netherlands (registration
number 2016.539; Dutch Trial Registry NL59977.029.16).
Participants were recruited via invitation letters, which were sent
to a random sample of individuals born between 01/01/1947
and 31/12/1956, drawn from the respective local population
registries. Invitation letters were sent, and responders were
screened for eligibility. All participants provided written
informed consent prior to commencing the on-site assessments.
Screening Procedures
Initial screening consisted of a telephone interview assessing
the following eligibility criteria: aged 61–70 years, retired or
working part-time, community dwelling (living independently),
able to read a newspaper or text on a smartphone, speak
Norwegian/German/Dutch, able to walk 500 meters without a
walking aid, and available for home visits during the following 6
weeks. Those already participating in an organized exercise class
(>1/week), undertaking moderate-intensity physical activity
(≥150 min/week in the previous 3 months), or with long-
term travel plans (>2 months) within the next 6 months
were excluded. A web-based risk screening tool (14) was
used to describe participants’ risk of long-term accelerated
functional decline. Medical screening ensured that exercise
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was not contraindicated. The final exclusion criteria included
cognitive impairment (Montreal Cognitive Assessment (MoCA)
≤24 points) (15) or depression (defined as acute depression by a
health professional at assessment in Trondheim and Amsterdam,
as major depression with CES-D (16) cut-off of >24 points
in Stuttgart.
Interventions
Of the three treatment groups, two received an active
intervention (aLiFE or eLiFE) using the activity framework (13)
and one acted as a control group. In short, the programme
consisted of strategies to (a) improve balance, (b) increase muscle
strength, and (c) reduce sedentariness and increase physical
activity. The aLiFE programme was adapted to young seniors
to be more challenging than the LiFE programme. The initial
development and evaluation of aLiFE is published elsewhere
(17). In addition, the programme comprised a behavioral change
framework, aiming to turn activity intentions into a habit by
embedding activities into daily life (18).
The eLiFE intervention was delivered to participants via
the PreventIT application on a smartphone and a smartwatch
through video clips, pictures, and text/verbal instructions for
each activity. The eLiFE participants were provided with both an
android phone and a smartwatch they could use during the entire
study period. aLiFE participants received a paper-based manual
with descriptions and instructions for the same activities.
The intervention was delivered actively for 6 months post-
randomization. Participants in aLiFE and eLiFE received six and
four home visits from trainers, respectively, plus three phone-
calls. After the 6 month active intervention period, participants
were encouraged to continue with their personalized activity
programme for the next 6 months, without the assistance from
trainers (unsupervised follow-up).
The control group participants received one home
visit entailing a two-page written summary of the WHO
recommendations for physical activity (19).
Sample Size
No sample size calculation was performed for this study, as it is a
feasibility study not designed to conclude on effectiveness.
Randomization
Participants were randomized following the 7-day activity
monitoring at baseline (T1), using a web-based randomization
procedure developed, used and run by the Clinical Research Unit
Central Norway, at NTNU, Norway. The randomization was
stratified to clinical sites and performed by block randomization,
where block sizes varied. One non-blinded person at each clinical
site performed the web-based randomization. Recruitment
continued until 60 participants completed the first home visit per
study site.
Blinding
Pre-intervention measures were assessed by trained research
and medical staff, prior to randomization. Post-intervention
measures were collected by personnel blinded to group
allocation. Due to the nature of the intervention, it was not
possible to blind participants or the instructors delivering the
intervention. Outcome measures that identified group allocation
were collected by non-blinded research staff.
Assessment and Outcome Measures
Participants were assessed at baseline (T1), and 6 (T2)
and 12 months (T3) post-randomization. Participation was
evaluated based on adherence to the participant’s individual
intervention protocol. Information regarding the number of
home visits/calls received, and trial completion vs. withdrawn
were collected. Uptake and adherence to recommendations were
assessed monthly via email or post using a single question
(13), where each month of reporting was summarized as
full adherence (responded positively, and “all or more than
planned”), partial adherence (responded positively, and “but not
as much as intended”), or non-adherence (responded negatively).
Furthermore, the Exercise Adherence Reporting Scale (EARS)
(20) was completed by participants during T2 and T3 assessment.
For the feasibility and usability, adverse events and participant
progression throughout the trial were documented. Detailed
information was collected via questionnaires at T2 and T3
regarding the acceptability of the aLiFE and eLiFE interventions.
Participants were asked to report the type and difficulty level
of the activities they had integrated into their daily lives.
Intervention-specific questions were asked, to ascertain the
usefulness of the intervention components (training manuals,
home visits, personalisation, etc.) and whether activities had
become habitual (Self-Report Behavioral Automaticity Index,
SRBAI) (21). Focus group interviews were held after T1 with a
random sample of totalling 62 participants (24 aLiFE, 21 eLiFE,
and 17 Control).
To assess the technology (PreventIT application), the System
Usability Scale (SUS) (22) was used; a higher SUS score
indicated better product usability, with scores above 68 implying
average product usability (23). The Tele-healthcare Satisfaction
Questionnaire (TSQ-WT) (24) was used to evaluate benefit,
usability, self-concept, privacy and loss of control, quality of life
and wearing comfort. A total score was calculated ranging from
0 (no satisfaction) to 120 (extreme satisfaction). To quantify
the programme-specific usability, the application usage and the
activities selected within the application are reported.
Estimates of change were calculated for the main outcome
measures Late-Life Function and Disability Index (LLFDI) (25,
26) and the physical behavior complexity metric (27, 28). LLFDI
assesses function (ability to perform specific activities of daily
living) and disability (inability to take part in major life tasks
and social roles) in community-dwelling seniors. Behavioral
complexity was assessed in the domains of physical activity,
sleep and social participation. These data were collected using
AX3 sensors from Axivity (+/– 2g, 100Hz) attached to the
participant’s lower back and wrist which monitored the physical
activity over seven consecutive days.
The estimate of change was also calculated for secondary
outcome measures. The measures included data regarding
general health and function, medication use, neuropsychological
measures and physical function (13).
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The health economics were based on healthcare resource use
and health-related quality of life (HRQoL). Healthcare resource
used by participants was collected at T1, T2, and T3 through a
questionnaire developed for this study. HRQoL was assessed by
the 5-level EuroQol 5-dimension (EQ-5D-5L) instrument, with
higher scores indicating better quality of life (29), and by the
Short Form-12 (SF-12) survey (23).
Data Analysis
A complete data analysis plan was finalized before the T2
assessments started. We developed and ran all analyses blinded
to group allocation, before we added the randomization variable.
Descriptive statistics and t-tests were used to present the
data for participation, feasibility and usability, and technology.
Continuous data are presented as mean (SD) or median (25- and
75-percentils), and categorical data as counts and percentages.
The focus groups were audio recorded, transcribed verbatim and
translated into English for thematic analysis.
For the estimates of change, main (LLFDI and physical
behavioral complexity metrics) and secondary outcomemeasures
were used to evaluate changes in function fromT1 to T3 for eLiFE
and aLiFE vs. the control group. Linear mixed-models (LMMs)
were used, including factors for time point and study allocation,
as well as their interaction, and age and sex as independent
variables. Within-participant correlations were accounted for
by a participant-specific random intercept. Clinical sites were
treated as a fixed rather than random effect due to its low
number and were included as an independent variable. Estimates
of effect sizes for the differences between the three groups, and for
changes within the eLiFE and aLiFE groups, are provided asmean
differences for the outcome variables. In case of non-normality,
appropriate methods were used. The significance level was set to
0.01 to give some protection against false positive findings due
to multiple testing. A priori subgroup analyses were performed
for high and low risk of functional decline, and for full, partial
and non-adherence.
For economic evaluation, costs are expressed in Euro (e)
2017–18 prices. Health outcomes were measured in quality-
adjusted life years (QALYs), estimated using the HRQoL scores
generated from responses to the EQ-5D-5L, using the UK
(30), German (31), and the Dutch value set (32), with the
area under the curve approach and linear interpolation (33).
Mean difference in costs and QALYs between groups over the
12-month period were estimated using a seemingly unrelated
regression model (34), adjusted for baseline costs and baseline
EQ-5D scores. The incremental cost-effectiveness ratio (ICER)
and the incremental net health benefit (NHB) were calculated,
assuming a cost-effectiveness threshold of e30,000 to e40,000
per QALY. Uncertainty about the intervention being cost-
effective was evaluated using probabilistic sensitivity analysis
(PSA) and presented using cost-effectiveness acceptability curves
(CEACs) (35, 36).
RESULTS
In total 7,500 invitation letters were sent by mail to seniors
between 61 and 70 years of age (2000 in Trondheim, 1500 in
Stuttgart, and 4000 in Amsterdam). Following the three-step
screening process, 180 participants were successfully enrolled
into the study, accepted randomization and completed their first
home visit (n= 61 eLiFE, n= 59 aLiFE, n= 60 controls). Baseline
characteristics of participants completing the trial (n = 138)
vs. non-completers (n = 47) were not statistically significantly
different. The flow of participants from recruitment to trial
ending is shown in Figure 1.
Participant Characteristics
Table 1 presents the participants characteristics at baseline (T1)
for the three groups. Mean age for eLiFE (54.1% women), aLiFE
(50.8% women), and controls (51.7% women), were 66.4 (SD
2.3), 66.2 (SD 2.3), and 66.4 (SD 2.7) years, respectively. In
total, 152 (84.4%) participants reported no falls in the past 6
months. The medication usage and reported diseases were 2
(median numbers), whereas 29.4% reported no medication use.
The majority of participants (n = 139, 77.2%) had a low risk of
functional decline based on the risk screening tool. Preferred gait
speed was 1.4 m/sec.
Feasibility
Home Visits/Calls
All participants in the control group (n = 60) completed their
home visit and 93 of the 120 intervention participants (77.5%)
completed all scheduled home visits and phone calls during the
6 months intervention period (79% eLiFE/76% aLiFE). Two out
of 27 participants who did not complete all scheduled visits/calls
completed the first home visit only. Due to technological issues,
14 extra home visits were provided to eLiFE participants, with
two participants requiring more than one extra visit.
Activities Performed
At T2, participants reported whether and which of 25 possible
activities they had performed (Supplementary Figure 2).
On average, 9.1 (SD 5.1) activities were reported for eLiFE
and 10.0 (SD 5.8) activities for aLiFE. eLiFE participants
tended to select fewer activities but at more challenging
levels, while aLiFE participants trained at all levels of
difficulty. The “one-leg stand” was the most reported
activity (n = 67) in both intervention groups, followed
by “stair climbing” and “tandem walk” (both n = 58).
The least reported activity was square jumping on one leg
(n= 4).
Adherence
During the intervention period, 47 participants reported full
adherence (16 eLiFE, 11 aLiFE, 20 controls), 88 reported partial
adherence (28 eLiFE, 32 aLiFE, 28 controls), and 29 were non-
adherent to their intervention (10 eLiFE, 12 aLiFE, 7 controls).
During the unsupervised follow-up period, 34 participants
reported full adherence (10 eLiFE, 7 aLiFE, 17 controls), 73
reported partial adherences (26 eLiFE, 25 aLiFE, 22 controls),
and 40 were non-adherent to their intervention (10 eLiFE, 20
aLiFE, 10 controls). At T2 and T3, the participants’ (n = 137)
EARS scores were on average 12.20 (SD 2.29, range 6–18) for
eLiFE; 11.85 (SD 2.44, range 6–18) for aLiFE; and 11.61 (SD
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FIGURE 1 | Flow chart.
2.07, range 7–19) for controls. Although the adherence reporting
was not set up as a motivating factor, participants reported it
as motivating.
‘more like a thing about “you’re in a project”, and to note whether
you’ve done anything or everything, so just a reminder from you’
(aLiFE participant, Trondheim)
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Satisfaction
Participants’ satisfaction with aLiFE and eLiFE is shown in
Table 2. For habit formation (SRBAI), the scores at T2 and
T3 were similar (4.57, SD 1.39, and 4.65, SD 1.38) indicating
that habits formed during the first period (T1–T2) were
sustained at follow-up (T3) (Supplementary Table 4). Some
participants in the focus groups reported that many activities had
become habitual, whereas some still required active thought and
tangible reminders.
“I don’t even have to think of it. The moment I grab my toothbrush,
I do one leg stance. That really became automatic.” (eLiFE
participant, Amsterdam)
“I don’t know, tandem walk through the hall and things like
that, they would not fit into my daily routine, so I perform these
exercises during my daily workout.” (aLiFE participant, Stuttgart)
The human factor, using instructors in both groups, were highly
valued by the participants.
“They [instructors] always showed it and demonstrated it and
we always did it together. . . , so that was really ideal.” (eLiFE
participant, Stuttgart)
Adverse Events
During the 12-month trial period, twelve negative events were
reported, with nine adverse reactions to the intervention and
TABLE 1 | Participant characteristics.
aLiFE eLiFE Control
n = 59 n = 61 n = 60
Age, years, mean (SD) 66.19 (2.32) 66.43 (2.33) 66.4 (2.71)
Gender, female, n (%) 30 (50.8%) 33 (54.1%) 31 (51.7%)
Height, cm, mean (SD) 171.95 (9.04) 169.77 (9.43) 170.95 (9.17)
Weight, kg, mean (SD) 81.29 (17.24) 80.10 (16.24) 78.42 (16.05)
Living alone, n (%) 21 (63.8%) 18 (70.5%) 22 (63.3%)
Pain during rest, 0–10,
median (25–75-perc.)
1.0 (1.0–3.0) 1.0 (1.0–3.0) 2.0 (1.0–4.0)
Pain during walking, 0–10,
median (25–75-perc.)
2.5 (1.0–4.0) 2.0 (1.0–4.5) 2.0 (1.0–4.0)
Falls in past year n (%)
0 53 (91.4%) 51 (83.6%) 47 (78.3%)
1 4 (6.9%) 10 (16.4%) 6 (10.0%)
2+ 1 (1.7%) 0 (0) 7 (11.7%)
Economic satisfaction, n (%)
Good 23 (39.7%) 23 (37.7%) 27 (45.0%)
Sufficient 22 (37.9%) 31 (50.8%) 23 (38.3%)
Poor/bad 13 (22.4%) 7 (11.5%) 10 (16.7%)
Total number comorbidities,
median (25–75-perc.)
2.0 (1.0–4.0) 2.0 (1.0–3.0) 2.0 (1.0–3.0)
Total number medication,
median (25–75-perc.)
2.0 (1.0–4.0) 2.0 (1.0–3.0) 2.0 (1.0–4.0)
Diagnosis of Arthritis* n (%) 19 (32.8%) 18 (29.5%) 20 (33.3%)
Diagnosis of Cardio-
vascular disease* n (%)
9 (15.5%) 14 (23.0%) (30.0%)
three falls during testing. The nine adverse reactions were
classified as mild/moderate of which seven were pain/soreness,
one a swollen knee, and one leg stiffness/tiredness. In addition,
the subjects reported a further 19 serious adverse events as well as
28 other events, all of which were unrelated to the intervention.
eLiFE Usage
During the 12-month trial period, 58 out of 61 eLiFE participants
used the application for on average 179.6 days (range 1–362
days), with 129.8 usage days until T2, and 49.7 usage days
between T2 and T3 (Figure 2). Nineteen participants stopped
using the application after T2. Over the 12 month period eLiFE
participants selected on average 10.7 activities (range 1–25), and
made on average 2.4 upgrades to more challenging activities
(range 0–13).
eLiFE Acceptability
The mean SUS score for eLiFE participants was 62.04 ± 15.75,
range 25–100 at T2, and 60.54 ± 15.11 range 27.5–90, at T3. The
mean value of the TSQ-WT was 73.4 out of 120 (±15.42, range
36–100) at T2 and 71.05/120 (±16.20, range 40–104) at T3. The
PreventIT system was, based on the scores of these two tests,
regarded around average in terms of usability, which was also
reflected in the focus group data, with some frustrations with the
technology, but generally happiness with the overall concept:
“I think that overall the technology aspect was not mature enough.”
(eLiFE participant, Stuttgart)
“The idea is very good of course.” (eLiFE
participant, Amsterdam)
Estimates of Change
No significant differences in change between the three
groups were found for the primary outcome measures,
LLFDI consisting of six variables and the physical behavior
complexity metric (p > 0.01), or secondary outcomes (p > 0.01)
(Supplementary Table 1). For several of the outcomes, all groups
showed improvements over time (Supplementary Tables 2, 3,
and Supplementary Figure 3).
Health Economic Evaluation
Although there was no significant difference in mean 12-month
costs per participant, the intervention groups showed lower
overall costs (aLiFE vs. control: e-116, 95% CI: −1,340 to
1,108, eLiFE vs. control: e-25, 95% CI: −1,173 to 1,123, see
Table 3). Regarding the QALYs, aLiFE was associated with more
QALYs (0.0060, 95% CI: −0.0119 to 0.0239) while eLiFE was
associated with lower (−0.0063, 95% CI: −0.0254 to 0.0127),
but both differences were not statistically significant. Therefore,
compared to control, aLiFE was associated with lower costs and
more QALYs and at the thresholds considered, the NHBs were
positive (0.0099 and 0.0089) and the probability of being cost-
effective was 66.3 and 68.2% (Supplementary Figure 1), whereas
for eLiFE, the incremental NHBs were both negative.
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TABLE 2 | Feasibility and acceptability of the technology delivered eLiFE and the traditional aLiFE version of the intervention.
Elements of the intervention Range* 6 months (T2) 12 months (T3)
aLiFE eLiFE aLiFE eLiFE
aLiFE Manual, mean (SD) 1–7 5.6 (1.1) – 5.3 (1.2) –
aLiFE planning and monitoring forms, mean (SD) 1–21 14.2 (13.7) – 12.3 (4.2) –
eLiFE virtual trainer, mean (SD) 1–7 – 5.1 (1.4) – 5.2 (1.4)
eLiFE planning and messaging, mean (SD) 1–28 – 18.9 (4.3) – 17.7 (14.4)
Perceived improvements in strength, balance and physical activity, mean (SD) 1–28 16.7 (2.2) 16.8 (2.2) 16.1 (2.7) 16.3 (2.4)
Helpfulness of the personal instructor, mean (SD) 1–7 6.5 (0.7) 6.2 (1.1) 6.4 (1.0) 5.95 (1.04)
Ease of performing activities, mean (SD) 1–7 4.6 (1.5) 5.0 (1.3) 4.7 (1.4) 5.2 (1.3)
Safety of activities, mean (SD) 1–7 5.8 (1.5) 6.1 (1.1) 5.8 (1.7) 5.9 (1.2)
Integration of activities into daily life, mean (SD) 1–7 4.7 (1.5) 4.9 (1.5) 4.6 (1.3) 5.1 (1.3)
*With maximum score as the best score.
FIGURE 2 | eLiFE participants’ interactions with the app.
DISCUSSION
The PreventIT feasibility trial set out to evaluate aLiFE and
eLiFE in young seniors, including participation and adherence,
feasibility and usability, and acceptability of smartphone
application-based intervention delivery. Findings aim to guide
future definitive trials in this important target group for
prevention of functional decline at later age. Recruitment of
this target group and the interventions were feasible concerning
intervention uptake and satisfaction. The behavior of participants
changed during the 6 month lifestyle-integrated intervention
programme, with more challenging everyday routines. All
three groups improved in some of the clinical outcome
measures over time, without significant group differences
in primary or secondary outcomes. This may suggest that,
improved function and behavioral change can be achieved in
different ways. Furthermore, participants were satisfied with
both the technology-based version and the traditional delivered
paper-based version, but the “human element” of involving
an instructor was valued as highly motivating. To increase
satisfaction and uptake, future trials could explore further
personalisation of the interventions.
An extensive protocol for screening and testing of participants
was applied. The majority of participants completed all trial
assessments, with 87% completing the 6-month post-test and
77% completing the 12-month follow-up assessment. In contrast,
there was a higher number of withdrawals and dropouts during
initial screening and testing. To avoid unnecessary burden
on participants, assessments, and intervention methodologies
should be kept as brief as possible.
In addition to the relatively high completion rate and low
number of drop outs, the majority of participants answered
positively concerning adherence, although many reported not
doing as much activities as they had planned. Additional home
visits were required due to technical issues with the technology
system during the intervention period, which improved based
on the participants’ feedback. The short period available for
developing and testing the technology in this project may explain
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TABLE 3 | Costs, EQ-5D scores, QALYs, and cost-effectiveness results.
aLiFE (n = 59) eLiFE (n = 61) Control (n = 60)
Mean (SE) 95% CI Mean (SE) 95% CI Mean (SE) 95% CI
Total costs 1,616 (330) 951 to 2,281 1,764 (269) 1,223–2,306 1,729 (540) 643–2,816
Incremental costsa −116 −1,340 to 1,108 −25 −1,173 to 1,123 –
Baseline EQ-5D 0.8717 (0.0189) 0.8338 to 0.9096 0.8850 (0.0123) 0.8604 to 0.9097 0.8973 (0.0192) 0.8589 to 0.9357
6-month EQ-5D 0.8949 (0.0159) 0.8630 to 0.9268 0.8849 (0.0185) 0.8479 to 0.9219 0.9068 (0.0203) 0.8662 to 0.9474
12-month EQ-5D 0.9090 (0.0125) 0.8839 to 0.9341 0.9004 (0.0169) 0.8665 to 0.9344 0.9156 (0.0161) 0.8834 to 0.9479
Total QALYs 0.8926 (0.0142) 0.8641 to 0.9211 0.8888 (0.0149) 0.8589 to 0.9187 0.9066 (0.0181) 0.8703 to 0.9429
Incremental QALYsb 0.0060 −0.0119 to 0.0239 −0.0063 −0.0254 to 0.0127 –
ICER (e/QALY) (intervention vs. control) Index – Comparator
Incremental NHB at
30,000 e/QALY 0.0099 −0.0071 –
40,000 e/QALY 0.0089 −0.0069 –
probability pf cost-effectiveness at
30,000 e/QALY 66.3% – –
40,000 e/QALY 68.2% – –
aCosts adjusted for baseline resource use, age and sex, showing differences in costs between the intervention group and control.
bQALYs adjusted baseline HRQoL, age and sex, showing difference in QALYs between the intervention group and control.
several of the technical difficulties the participants experienced.
Despite the immature technology, most participants liked the
overall concept and continued using the system after the active
intervention period. With further improvements, a system using
smartwatches and smartphones to deliver an intervention to this
target population is realistic (9). The higher system use during the
initial active intervention period could indicate that participants
need the system when learning the concept, or illustrate that
interest in new applications is highest in the beginning1. Further
development of the application should therefore include tailoring
the intervention to different phases of use.
An important strength of the PreventIT project has been the
development and testing of explicit links between behavioral
change techniques and intervention components, which has been
a major gap in previous studies. Furthermore, the systematic
collection of adherence data, which is feasible when using
smartphones as platform for delivering the intervention, is
another strength. Finally, the use of lifestyle-integration of the
intervention may have increased adherence to exercise over
longer periods.
We included relatively healthy participants, with all groups
showing improvements over time regardless of group allocation.
For future improvements of the interventions, the dosage and
intensity for a rather fit group should be considered, along with
the possible benefit to the control group, becoming aware of their
health situation because of extensive assessments, along with
learning how to be more physically active. The monthly question
regarding adherence levels may have served as a reminder to
be active in all three groups, rather than being an observational
outcome measure only. Progress on difficulty level was part of
the interventions, but how and when to progress should be
evaluated in future trials, as few participants progressed through
1Available online at: https://www.gartner.com/en/research/methodologies/
gartner-hype-cycle.
all available difficulty levels of the activities. Furthermore,
complexity in behavior as an experimental outcome measure was
promising, and has the potential to detect changes even in high
functioning individuals—research should explore this further in
future trials.
For the purpose of estimating cost-effectiveness, a self-
reported healthcare resource use questionnaire was employed.
GP visits, inpatient days, and physiotherapy visits were effectively
collected, demonstrating the feasibility. Only small differences in
QALYs between intervention and control groups were observed,
most likely due to high baseline EQ-5D-5L scores and thereby
poor discriminative ability due to ceiling effects (37). Alternative
tools should be considered for future trials if similar target groups
are included.
Limitations
An important study limitation is the inclusion of a relatively
healthy group of young seniors, which might not represent
the general population of that age group. Participants were
not excluded based on their IT literacy, which might have
influenced the results of the study. We did however provide
participants without any smartphone experience one extra home
visit, with information on how to use a smartphone prior
to starting the home visits in week one. Further research is
needed to involve participants at medium risk for long-term
functional decline when delivering physical activity promotion
interventions (17). For the majority of participants in our
study, the exercise activities might not have been challenging
enough and not practiced for long enough. Nevertheless, all
groups showed improvements over time, suggesting that even
in this target group, health benefits can be achieved. Most
importantly, this feasibility trial reflects the challenge of reaching
and engaging those people at risk, who would benefit most from
the intervention.
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CONCLUSION
In conclusion, the PreventIT feasibility RCT has shown
that it is possible to deliver a 6 month lifestyle-integrated
intervention programme to young seniors. Feasibility, usability
and acceptability of eLiFE using an ICT platform, combining
technology with behavior change techniques, was as successful
as delivering the intervention using traditional paper-based
manuals. This intervention was shown to have the potential to
change participants’ physical activity behavior and make daily
routines more challenging. Participants liked the concept and
many of them were still using either the application or the
manual during the unsupervised follow-up period. Possibilities
for further development of interventions targeting young seniors
include longer follow up periods, specific recruitment strategies
for those at higher risk for future functional decline and further
adaptations of the content of the intervention delivered.
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